KIR3DL1 and systemic lupus erythematosus: Sera from 3 of the 10 SLE patients with KIR reactivity to >3 KIRs blocked the binding of the anti-KIR2DL1/2DS1 mAb EB6B (SLE3, SLE138, and SLE206; Figures 2A,B).